Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-642-7 | CAS number: 144-83-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Endpoint conclusion:
- adverse effect observed
- Study duration:
- subacute
- Species:
- rat
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
There are three reports available to assess the reproductive potential of sulfapyridine.
Rakesh K. Sharma and N.R. Kalla, 1994 precluded the testis as a site of action of sulfapyridine and confirms earlier observations that the effect of sulfapyridine was post-testicular at the level of the epididymis. In this study, sulfapyridine at doses of 60, 120 and 250 mg kg/ body weight suspended in 0.5 mL of corn oil was administered to male rats (six animals in each group) by oral intubation daily for 60 days. Sperm motility was reduced significantly at the higher dose levels of sulfapyridine. An increased frequency of abnormal spermatozoa was seen. A significant fall (56%) occurred in the cauda sperm of animals given sulfapyridine (250 mg). Total sperm reserves also decreased (28.91% and 34.93%) at the highest dose levels of sulfapyridine. A marginal (3.88%) decrease was seen in germinal height and tubular diameter of the sulfapyridine treated group. The test substances did not affect the earlier stages of spermatogenesis that proceed to form step 19 spermatids.
In the study conducted by Jeremy V. Kredentser, et al. 1991, 20 mature Sprague-Dawley rats were assigned to a treatment (400 mg/kg test substance daily), or a control group. When killed at 10 days gestation, there was a significant reduction in the proportion of fertilized oocytes between control and treatment groups. Test substance treatment had a negative effect on fertilization rates. One resorption occurred in a treatment group rat; this was classified as an adverse (non-pregnancy) outcome. These findings suggest an adverse effect of sulphapyridine on female fertility. But differences did not reach the level of statistical significance.
Another study performed by G. Chaturapanich, et al. 1999 investigated the effects of sulphapyridine on the transport of spermatozoa through the rat epididymis and on the contractility of the epididymal duct. Sulphapyridine increased the rate of sperm transport from the caput to the distal cauda epididymis by approximately 3 days after treatment with sulphapyridine at adosage of 450 mg/kg for 38-52days. The decrease in transit time may be associated, in part, with changes in the responsiveness of the epididymis to adrenergic nerve activities and a reduction in spermatocrit.
Based on the results of the existing studies, sulfapyridine can cause the adverse treatment-related effects on male and female fertility.
Short description of key information:
sulfapyridine can cause the adverse treatment-related effects on the fertility.
Justification for selection of Effect on fertility via oral route:
This study provided the scientific details and fulfill scientific principles.
Effects on developmental toxicity
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the results of the existing studies, sulfapyridine can cause the significant adverse effects on the fertility.
Thus, sulfapyridine can beclassified as category 2 for reproductive toxicity according to CLP (Regulation EC No.1272/2008).
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.